Intracellular Delivery: Exploiting Viral Membranotropic Peptides

Author(s): Stefania Galdiero, Mariateresa Vitiello, Annarita Falanga, Marco Cantisani, Novella Incoronato, Massimiliano Galdiero

Journal Name: Current Drug Metabolism

Volume 13 , Issue 1 , 2012

Become EABM
Become Reviewer


Recent advances in the understanding of cellular and molecular mechanisms of the pathogenesis of several diseases offer the possibility to address novel molecular targets for an improved diagnosis and therapy. In fact, in order to fulfill their function, macromolecular drugs, reporter molecules, and imaging agents often require to be delivered into specific intracellular compartments, usually the cytoplasm or the nucleus. From a medical perspective, biological membranes represent a critical hindrance due to their barrier-like behaviour not easily circumvented by many pharmacologically-active molecules. Therefore, identifying strategies for membrane translocation is essential. Several technologies have been designed to improve cellular uptake of therapeutic molecules, including cell-penetrating peptides (CPPs). These peptides, which are able to efficiently translocate macromolecules through the plasma membrane, have attracted a lot of attention, and new translocating peptides are continuously described. In this review, we will focus on the viral derived peptides, and in particular those derived by viral entry proteins that may be useful as delivery vehicles due to their intrinsic properties of inducing membrane perturbation.

Keywords: Cell-penetrating peptides, endocytosis, intracellular delivery, membrane fusion, viral fusion proteins, oligonucleotide, beta-galactosidase protein, neuropeptide, Penetratin, amphipathic

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [93 - 104]
Pages: 12
DOI: 10.2174/138920012798356961

Article Metrics

PDF: 31